Outpatient Treatment in Low-Risk Pulmonary Embolism Patients Receiving Direct Acting Oral Anticoagulants Is Associated With Cost Savings

Direct oral anticoagulants (DOAC) are first line treatment for pulmonary embolism (PE). Treatment of acute PE is traditionally hospital based and associated with high costs. The aims of this study were to evaluate potential cost savings with outpatient DOAC treatment compared to inpatient DOAC treat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghazvinian, Raein, Elf, Johan, Löfvendahl, Sofia, Holst, Jan, Gottsäter, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Impact of Thrombosis on Quality of Life
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711226/
https://www.ncbi.nlm.nih.gov/pubmed/33259227
http://dx.doi.org/10.1177/1076029620937352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711226/
https://www.ncbi.nlm.nih.gov/pubmed/33259227
http://dx.doi.org/10.1177/1076029620937352

Ejemplares similares